Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer

Anticancer Research

Volumn 34, Issue 3, 2014, Pages 1163-1166

  Mohr, Sharif B ^a   Gorham, Edward D ^a,b   Kim, June ^a   Hofflich, Heather ^b   Garland, Cedric F ^a,b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Epidemiology; Meta analysis; Mortality; Survival; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; DOSE RESPONSE; FATALITY; HAZARD RATIO; HUMAN; META ANALYSIS; VITAMIN BLOOD LEVEL; BREAST TUMOR; EPIDEMIOLOGY; FEMALE; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL; SURVIVAL RATE; VITAMIN D DEFICIENCY;

BREAST CANCER; EPIDEMIOLOGY; META-ANALYSIS; MORTALITY; SURVIVAL; VITAMIN D;

BREAST NEOPLASMS; FEMALE; HUMANS; PROGNOSIS; SURVIVAL RATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84899690442     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. American Cancer Society. Cancer facts and figures, 2011 http://www.cancer.org/Research/CancerFactsFigures/CancerFactsF igures/cancer-facts-figures-2011. Accessed August 15, 2011. Atlanta: American Cancer Society.
2. Ferlay J, Bray F, Pisani P and Parkin D: GLOBOCAN 2008: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. http://www-dep.iarc.fr/. Accessed 10 July 2011.
3. Villasenor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A and Neuhouser ML: Associations of serum 25- hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control 24: 759-67, 2012.
4. Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T, Brouckaert O, Peuteman G, Laenen A, Verlinden L, Kriebitzsch C, Dieudonne AS, Paridaens R, Neven P, Christiaens MR, Bouillon R and Wildiers H: Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis 33: 1319-26, 2012.
5. Tretli S, Schwartz GG, Torjesen PA and Robsahm TE: Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a populationbased study. Cancer Causes Control 23: 363-370, 2012.
6. Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D and Chang-Claude J: Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study: Breast cancer research 13: 74, 2012.
7. Goodwin PJ, Ennis M, Pritchard KI, Koo J and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27: 3757-3763, 2009.
8. Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA and Hulka BS: Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr 2: 283-291, 1999.
9. Hiatt RA, Krieger N, Lobaugh B, Drezner MK, Vogelman JH and Orentreich N: Prediagnostic serum vitamin D and breast cancer. J Natl Cancer Inst 90: 461-463, 1998.
10. Deeks JH, J: Statistical algorithms in Review Manager 5. The Cochrane Collaboration 2007.
11. Tierney JF, Stewart LA, Ghersi D, Burdett S and Sydes MR: Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16, 2007.
12. Deeks J, Altman D and Bradburn M: Statistical methods for examining heterogeneity and combining results from several studies in a meta-analysis. In: Egger M, Davey Smith G, Altman D, editors. Systematic reviews and health care: meta-analysis in context. London: BMJ Publications p. 285-312, 2002.
13. Lewis S and Clarke M: Forest plots: trying to see the wood and the trees. BMJ 322: 1479-1480, 2001.
14. Yeh J and D'Amico F: Forest plots: data summaries at a glance. J Fam Pract 53: 1007, 2004.
15. DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
16. Garland CF, Gorham ED, Mohr SB and Garland FC: Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19: 468-483, 2009.
17. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR and Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591, 2007.
18. National Academy of Sciences. Commitee to Review Dietary Reference Intakes for Vitamin D and Calcium. Washington DC: National Academies Press, 2010.
19. Garland F, Garland C, Gorham E and Young J Jr: Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622, 1990.
20. Grant WB: Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164: 371-7, 2003.
21. Vieth R: Vitamin D and cancer mini-symposium: the risk of additional vitamin D. Ann Epidemiol 19: 441-445, 2009.